- cafead Aug 31, 2023 at 12:12: PM
via Airfinity analysis on data from the Wegovy trial on cardiovascular outcomes reveals that even after a 65% rebate on the list price, it will cost $1.1m to prevent one heart attack, stroke or cardiovascular death.
The SELECT trial found that the drug semaglutide, sold under brand names Wegovy and Ozempic, resulted in a 20% reduction in major adverse cardiovascular events (MACE) in the enrolled population.
article source
The SELECT trial found that the drug semaglutide, sold under brand names Wegovy and Ozempic, resulted in a 20% reduction in major adverse cardiovascular events (MACE) in the enrolled population.
article source